Alcon's PATANASE(R) Nasal Spray Approved By FDA For Treatment Of Nasal Allergy Symptoms (Medical News Today)
Alcon, Inc. (NYSE: ACL) announced that the U.S. Food and Drug Administration (FDA) has approved PATANASE (olopatadine hydrochloride) nasal spray for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of age and older. PATANASE nasal spray, an extension to Alcon's market-leading ocular allergy product line, will be available in May of this year.

Cattle Update: Intervet Receives Combination Approvals For Zilmax (CattleNetwork.com)
MILLSBORO, Del. (April 17, 2008) Intervet Inc. announces combination approvals for its performance-technology product, Zilmax.

Sirtex Receives FDA Approval For FAST Clinical Trial (Medical News Today)
Sirtex, a leading developer of targeted and innovative cancer therapies, has received FDA approval under Investigational Device Exemption to conduct the first clinical trial to evaluate the safety of concurrent administration of FOLFOX6 and bevacizumab, an anti-angiogenic, with Selective Internal Rad